JBS

Jbs NV

Add to Watchlist

Advanced Chart

13.730

+0.1(0.734%)1D

Line

Candle

YTD

High

13.860

Open

13.700

VWAP

13.74

Vol

4.84M

Mkt Cap

15.23B

Low

13.595

Amount

66.52M

EV/EBITDA(TTM)

4.77

Total Shares

1.11B

34.95B

EV/OCF(TTM)

P/S(TTM)

JBS N.V. is Netherlands-based Company primarily engaged in the food and protein processing industry. The Company focuses on the production and global distribution of animal protein and food products to retail, foodservice, and industrial clients. The Company has in its offer poultry, pork, beef, lamb, fish and plant-based products. In addition, the Company operates in sectors such as leather, biodiesel, fertilizers, collagen, sausage casings, hygiene and beauty, metal packaging, transportation, waste management solutions. The Company is active worldwide in 17 countries and is listed on The New York Stock Exchange (NYSE).

7 Analyst Rating

Wall Street analysts forecast JBS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JBS is 20.01 USD with a low forecast of 17.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

0 Hold

0 Sell

Strong Buy

Current: 13.730

Low

17.00

Averages

20.01

High

22.00

Current: 13.730

Low

17.00

Averages

20.01

High

22.00

BofA

Buy

maintain

$20 -> $21

2025-11-17

New

Reason

BofA

Price Target

$20 -> $21

2025-11-17

New

maintain

Buy

Reason

BofA raised the firm's price target on JBS to $21 from $20 and keeps a Buy rating on the shares as the firm raised estimates for JBS following the company's Q3 report.

Mizuho

Outperform -> NULL

downgrade

$22 -> $20

2025-10-28

Reason

Mizuho

Price Target

$22 -> $20

2025-10-28

downgrade

Outperform -> NULL

Reason

Mizuho lowered the firm's price target on JBS to $20 from $22 and keeps an Outperform rating on the shares.

BofA

Buy

downgrade

$21 -> $20

2025-10-16

Reason

BofA

Price Target

$21 -> $20

2025-10-16

downgrade

Buy

Reason

BofA lowered the firm's price target on JBS to $20 from $21 and keeps a Buy rating on the shares. As China remains closed for Brazilian chicken, the firm lowers its 2025 and 2026 EBITDA estimates by about 3% each and its EPS forecasts by 9% and 8%, respectively, mainly on lower short-term margins at Seara.

JPMorgan

Lucas Ferreira

Overweight

downgrade

$21 -> $20

2025-10-14

Reason

JPMorgan

Lucas Ferreira

Price Target

$21 -> $20

2025-10-14

downgrade

Overweight

Reason

JPMorgan analyst Lucas Ferreira lowered the firm's price target on JBS to $20 from $21 and keeps an Overweight rating on the shares. The firm sees as a more challenging U.S. chicken margin in the near-term for the company following a 23.5% price decline from the recent peak. Prices are expected to fall after the summer, but placements and better mortality indicate the industry is pumping more supply than expected, the analyst tells investors in a research note.

JPMorgan

Overweight

maintain

$21

2025-09-03

Reason

JPMorgan

Price Target

$21

2025-09-03

maintain

Overweight

Reason

JPMorgan raised the firm's price target on JBS to $21 from $20.50 and keeps an Overweight rating on the shares. The firm increased EBITDA estimates post the company's stronger than expected Q2 report. It sees JBS's strong earnings momentum for chicken, pork and Australia offsetting weaker U.S. beef.

BMO Capital

Andrew Strelzik

Outperform

maintain

$20 -> $19

2025-08-15

Reason

BMO Capital

Andrew Strelzik

Price Target

$20 -> $19

2025-08-15

maintain

Outperform

Reason

BMO Capital analyst Andrew Strelzik lowered the firm's price target on JBS to $19 from $20 and keeps an Outperform rating on the shares after its Q2 results. GAAP EBITDA of $1.37B fell short of the firm's $1.47B estimate as BMO has underestimated the accounting conversion impact in Seara, with results also having included the $250M mark-to-market headwind, implying underlying fundamentals tracked ahead of expectations, the analyst tells investors in a research note.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Jbs NV (JBS.N) is 7.86, compared to its 5-year average forward P/E of 8.53. For a more detailed relative valuation and DCF analysis to assess Jbs NV 's fair value, click here.

Forward PE
Forward EV/EBITDA
Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

8.53

Current PE

7.86

Overvalued PE

9.72

Undervalued PE

7.34

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

5.63

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

6.42

Undervalued EV/EBITDA

4.84

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.28

Current PS

0.00

Overvalued PS

0.50

Undervalued PS

0.06